Living with Diabetes? Check out our site for you

Healthcare professional? This is your dedicated site.

You are here

Home » Therapy » Multiple Daily Injections
multiple daily injections

MULTIPLE DAILY INJECTIONS

MULTIPLE DAILY INJECTIONS

THE FIRST LINE
OF DEFENCE

Multiple Daily Injections (MDI) is typically the first line of treatment in Australia and is defined as the administration of three or more insulin injections per day. This includes one injection of long-acting insulin in the evening and an injection of rapid or short-acting insulin before each meal.

Long-acting insulins do not have a pronounced peak effect as they are designed to replace physiologic basal insulin secretion. They are designed to dissipate slowly and evenly into the bloodstream for approximately 24 hours following administration.

On this regimen, the physiologic replacement of mealtime insulin secretion is administered three times a day using rapid or short-acting insulin. These injections are given before meals and are typically adjusted to match food intake using an insulin-to-carbohydrate ratio. 

When compared to regular insulin, rapid-acting insulin is typically preferred because it provides better physiologic insulin coverage for meals and more closely matches the glucose rise that occurs in response to meals. The peak action time of rapid-acting insulin occurs at approximately 1-1.5 hours after administration. This correlates well with the digestive time of most meals.

iPro2 provides more accurate data

There are times when, using the fingerstick method, you may miss your patients’ hypos or hypers, as seen in the graph above.  Fingersticks can only tell you so much. By using iPro2, the only available professional CGM designed for the masked collection of glucose data, you will enjoy more precise insights into your patients’ glycaemic profile.

LEARN MORE

Alternatives to MDI

MiniMed® 640G provides better control
The most advanced system on the market as at November 2015, the MiniMed® 640G Insulin Pump System^ with SmartGuard™ features technology that closely mimics the way a healthy pancreas delivers basal insulin to the body – giving your patients better control of their diabetes.

LEARN MORE

  • Even though long acting insulins are designed to last 24 hours without a pronounced peak, it does not last this long in many individuals, and in others may last longer
  • Some patients must divide their long acting insulin into two injections, with half of the dose administered in the morning and the other half administered in the evening
  • The acidic pH of long acting insulin can result in a slight burning sensation when it is administered.

i-port Advance offers a life with fewer injections 
Do you have patients who miss their regular injections because of needle phobia? i-port Advance is a new injection port designed to overcome the pain and anxiety associated with injections.

LEARN MORE

^Components sold separately. Automated insulin delivery is made possible through combining Medtronic insulin pump and continuous glucose monitoring technology.

YOU MAY BE INTERESTED IN

I-PORT ADVANCE

Offer your patients a life with fewer injections.

VIEW IT HERE

MINIMED® 640G INSULIN PUMP SYSTEM^

Discover better diabetes control for your patients.

VIEW IT HERE

LOW GLUCOSE SUSPEND STUDY

Compares the rates of severe hypos in patients using CSII versus SAP... therapy with the Low Glucose Suspend feature on

VIEW IT HERE

ONLINE LEARNING MODULES

Register your interest to receive access to learning modules.

VIEW IT HERE